Industries > Pharma > Deep Frozen Packaging Logistics Market Report 2022-2032

Deep Frozen Packaging Logistics Market Report 2022-2032

Forecasts by Type (Dry Shippers, Dry Ice Shipper), by Materials (Clinical Trials, Cell & Gene Therapies, Reagents, Cell Culture Media) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 14 January 2022
PAGES: 452
PRODUCT CODE: PHA1159
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA1159 Categories: , Tags: , , , ,

U.S. is One of the Key Region Across North America in the Management of Cold Storage Operations
COVID-19 has impacted deep-frozen packaging logistics market due to limited transit capacity. Due to material shortages, clinical trial disruptions, and FDA approval delays, COVID-19 hindered the development of new pharmaceutical medicines. Pharmaceutical wholesalers and distributors are at the heart of the American healthcare system. Despite the fact that regulatory limits are tightening, the biopharma industry is outsourcing more shipping and distribution tasks to third-party logistics companies. Electronic cargo monitoring, which incorporates near-real-time location and condition reporting, has become a popular option as a result.

The United States is often regarded as one of the most important markets for creating solutions for properly managing cold storage operations. As a result, the development of the market is projected to boost the deep-frozen packaging logistics industry. Pharmaceutical inventory management, such as vaccines and medicines, is an expensive activity that requires effective security measures for product quality preservation, which is expected to drive expansion in the US deep-frozen packaging logistics market.

Emerging Cell and Gene Therapies Industry
Emerging cell and gene therapies (CGTs) are shown great promise in the treatment of cancer, neurological illnesses, and a variety of other ailments. Between 2019 and 2025, the CGT sector is predicted to increase by 30%, and the move from clinical trials to commercial-scale manufacturing is currently considered inevitable.

CGTs provide issues for temperature-controlled logistics, which pharmaceutical firms are tackling. CGTs (as well as certain biological samples) need ultra-cold temperatures ranging from –4 °C and –20 °C to –80 °C, –120 °C, –150 °C, and beyond, in contrast to typical biological treatments that require temperature management.

Despite this, the CGT market is seeing a lot of investment. CGT developers raised $10.7 billion through IPOs, venture finance, and other sources between January and June 2020. The US Food and Drug Administration (FDA) said in January 2019 that it anticipates more than 200 investigational new drug (IND) submissions every year until 2025, citing the uptick.

CGTs are seen as potentially disruptive to established medicines because of their ability to cure illness. As a result, pharmaceutical firms are incorporating CGT into their expansion plans. According to the 2020 Biopharma Cold Chain Sourcebook issued by Pharmaceutical Commerce, temperature-controlled logistics account for approximately 18 percent of total biopharma logistics investment, despite the markets’ ongoing expansion.

The ultra-cold storage requirements of these items, as well as their customised nature, direct patient participation in a circular supply chain, and restricted industrial capacity, all pose challenges to a successful supply chain. Pharmaceutical companies are being compelled to outsource ultra-cold-chain services, including as temperature-controlled storage to biorepositories, to third parties. Biorepositories are essentially collections of human specimens and data, but their activities have evolved to encompass specimen processing, data management, storage, and distribution preparation.

The preservation of CGT items necessitates temperature-sensitive packaging. Specimens are subjected to severe temperatures ranging from –190 °C to 37 °C throughout their trips through manufacture, storage, and shipment. Biorepositories must provide adequate storage (primary) and transportation packaging (secondary).

Discover how to stay ahead
Our 450+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Deep Frozen Packaging Logistics Market. See how to exploit the opportunities.

Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), Porter’s Five Forces, & SWOT Analysis, product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry.

To access the data contained in this document please email contactus@visiongain.com

Discover sales predictions for the world market and submarkets

Type
• Dry Shippers
• Dry Ice Shipper

Materials
• Clinical Trials
• Cell & Gene Therapies
• Reagents
• Cell Culture Media

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

Market Analysis by Sub-segments
One the basis of type, the global deep frozen packaging logistics market is sub-segmented into dry shippers, and dry ice shipper. Dry shippers segment is projected to dominate the global deep frozen packaging logistics market on the basis of type with 63.91% market share in 2022 which is projected to reach 61.88% in 2032.

One the basis of materials, the global deep frozen packaging logistics market is sub-segmented into clinical trials, cell & gene therapies, reagents, and cell culture media. Clinical trials segment is projected to dominate the global deep frozen packaging logistics market on the basis of Materials with 45% market share in 2022 which is projected to reach 46.1% in 2032.

One the basis of region, the global deep frozen packaging logistics market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and MEA. North America region is projected to dominate the global deep frozen packaging logistics market on the basis of region with 36.6% market share in 2022 which is projected to reach 35.1% in 2032. The regional dominance is attributed to presence of tier I and tier II deep frozen logistic companies and one of the major region in the overall biopharmaceutical industry. However, Asia Pacific deep frozen logistic market is projected to witness highest CAGR of 5.50% over the forecast period from 2022 to 2032 owing to pharmaceutical market across emerging economies like India, China, & ASEAN.

CTA

By Region

• North America
• U.S.
• Canada

• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe

• Asia Pacific
• China
• Japan
• India
• South Korea
• Singapore
• Rest of Asia Pacific

• Latin America
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa

Deep Frozen Packaging Logistics Market Report 2022-2032
Need industry data? Please contact us today.

Leading companies and the potential for market growth
Overall world revenue for Deep Frozen Packaging Logistics market will surpass US$20 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Deep Frozen Packaging Logistics Market report helps you
In summary, our 450+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Deep Frozen Packaging Logistics Market, with forecasts for Type and Materials, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2032 for 5 regional and 17 key national markets– See forecasts for the Deep Frozen Packaging Logistics market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, and Japan, among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 22 of the major companies involved in the Deep Frozen Packaging Logistics market. Some of the company’s profiled in this report include Almac Group, Amerisource Bergen, B.P.L. GmbH, Catalent, Ceva, DHL, FedEx, Glatt GmbH, Kuehne + Nagel, Marken (A UPS Company), SkyCell, Thermo Fisher Scientific Inc., United Parcel Services, WuliuAir, Biocair, CSafe Global, Peli BioThermal Limited, T°Safe Group, Dryce Srl, IMP LOGISTICS, Yourway, and va-Q-tec among other prominent players.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Deep Frozen Packaging Logistics Market and leading companies. You will find data, trends, and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Deep Frozen Packaging Logistics Market Report 2022-2032: Forecasts by Type (Dry Shippers, Dry Ice Shipper), by Materials (Clinical Trials, Cell & Gene Therapies, Reagents, Cell Culture Media) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Deep Frozen Packaging Logistics Market Report 2022-2032


Download sample pages

Complete the form below to download your free sample pages for Deep Frozen Packaging Logistics Market Report 2022-2032


Latest Pharma news

Visiongain Publishes Biologics Market Report 2022-2032

The global biologics market was valued at US$382.85 billion in 2022 and is projected to grow at a CAGR of 8.82% during the forecast period 2022-2032.

04 July 2022

READ

Visiongain Publishes Liposomal Drug Delivery Devices Market Report 2022-2032

Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032.

21 June 2022

READ

Visiongain Publishes Nanotechnology in Drug Delivery Market Report 2022-2032

The global nanotechnology in drug delivery market was valued at US$53.0 billion in 2021 and is projected to grow at a CAGR of 18.7% during the forecast period 2022-2032.

20 June 2022

READ

Visiongain Publishes Respiratory Drug Delivery Technologies Market Report 2022-2032

The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032.

15 June 2022

READ

Categories